Gary C. Burgess, M.B., Ch.B. M. Med
2013
In 2013, Gary C. Burgess, M.B., Ch.B. M. Med earned a total compensation of $444.1K as Senior Vice President, Clinical Research, and Chief Medical Officer at Conatus Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,315 |
|---|---|
| Salary | $288,400 |
| Other | $50,425 |
| Total | $444,140 |
Med received $288.4K in salary, accounting for 65% of the total pay in 2013.
Med also received $105.3K in non-equity incentive plan and $50.4K in other compensation.
Rankings
In 2013, Gary C. Burgess, M.B., Ch.B. M. Med's compensation ranked 9,740th out of 12,286 executives tracked by ExecPay. In other words, Med earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,740 out of 12,286 | 21st |
Division Manufacturing | 3,611 out of 4,612 | 22nd |
Major group Chemicals And Allied Products | 1,141 out of 1,462 | 22nd |
Industry group Drugs | 888 out of 1,156 | 23rd |
Industry Pharmaceutical Preparations | 693 out of 890 | 22nd |
Source: SEC filing on April 28, 2014.
Med's colleagues
We found two more compensation records of executives who worked with Gary C. Burgess, M.B., Ch.B. M. Med at Conatus Pharmaceuticals in 2013.